Abbrea Capital’s Alnylam Pharmaceuticals ALNY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $213K | Hold |
|
|||||
|
2023
Q4 | $273K | Hold |
|
|||||
|
2023
Q3 | $252K | Hold |
|
|||||
|
2023
Q2 | $271K | Hold |
|
|||||
|
2023
Q1 | $285K | Sell |
|
|||||
|
2022
Q4 | $374K | Hold |
|
|||||
|
2022
Q3 | $315K | Hold |
|
|||||
|
2022
Q2 | $230K | Hold |
|
|||||
|
2022
Q1 | $257K | Hold |
|
|||||
|
2021
Q4 | $267K | Hold |
|
|||||
|
2021
Q3 | $297K | Hold |
|
|||||
|
2021
Q2 | $267K | Hold |
|
|||||
|
2021
Q1 | $222K | Buy |
|